Prospective Study on HIV-related Hodgkin Lymphoma

Clinical trial NCT01468740 · UNKNOWN

Trial details

NCT number: NCT01468740
Sponsor: Harlachinger Krebshilfe e.V.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

HIV-associated Hodgkin Lymphoma

Start date: 2004-03-01
Primary completion: 2012-02-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.